Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
Go back to Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data| (NASDAQ: PALI) | Delayed: 1.94 -0.09 (4.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.03 | 52 Week High | $ | |||
| Open | $2.02 | 52 Week Low | $ | |||
| Day High | $2.04 | P/E | N/A | |||
| Day Low | $1.94 | EPS | $ | |||
| Volume | 710,432 | |||||

